ADAM METZLER: Open Payments
NPI 1942710025 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$484 in 27 payments from 9 companies in 2025. Trend: 2023 $414 · 2024 $565 · 2025 $484
Food & beverage: $484
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 9 | $175 |
| PFIZER INC. | 7 | $119 |
| Exact Sciences Corporation | 3 | $55 |
| Medtronic, Inc. | 2 | $35 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| Novo Nordisk Inc | 1 | $22 |
| Merck Sharp & Dohme LLC | 1 | $15 |
| CooperSurgical, Inc. | 1 | $14 |
| Abbott Laboratories | 1 | $14 |
Products named: Dexcom G6 Transmitter, PREVNAR 20, The Cologuard Plus Collection Kit, INTELLIS ADAPTIVESTIM, Ozempic, AREXVY, BEXSERO, GARDASIL 9.
Industry payments across IN — which companies pay providers there.
